Teleflex
TFX
$116.40
Share price
-2.95%
Change (1 day)
-47.05%
Change (1 year)
Categories
Teleflex Incorporated, is an American company providing specialty medical devices for a range of procedures in critical care and surgery.
Revenue for Teleflex (TFX)
Revenue in 2025 (TTM): $3.01 Billion USD
According to Teleflex's latest financial reports the company's current revenue (TTM 
) is $3.01 Billion USD. In 2024 the company made a revenue of $3.04 Billion USD an increase over the revenue in the year 2023 that were of $2.97 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Teleflex from 1996 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | $3.01 B | -1.22% |
| 2024 | $3.04 B | 2.45% |
| 2023 | $2.97 B | 6.57% |
| 2022 | $2.79 B | -0.66% |
| 2021 | $2.80 B | 10.74% |
| 2020 | $2.53 B | -2.24% |
| 2019 | $2.59 B | 6% |
| 2018 | $2.44 B | 14.07% |
| 2017 | $2.14 B | 14.9% |
| 2016 | $1.86 B | 3.22% |
| 2015 | $1.80 B | -1.64% |
| 2014 | $1.83 B | 8.46% |
| 2013 | $1.69 B | 9.37% |
| 2012 | $1.55 B | 2.74% |
| 2011 | $1.50 B | -2.39% |
| 2010 | $1.54 B | -15.72% |
| 2009 | $1.83 B | -22.2% |
| 2008 | $2.35 B | 83.91% |
| 2007 | $1.28 B | -49.68% |
| 2006 | $2.54 B | 1.31% |
| 2005 | $2.51 B | 8.57% |
| 2004 | $2.31 B | 1.51% |
| 2003 | $2.28 B | 9.93% |
| 2002 | $2.07 B | 8.99% |
| 2001 | $1.90 B | 7.96% |
| 2000 | $1.76 B | 10.2% |
| 1999 | $1.60 B | 11.37% |
| 1998 | $1.43 B | 25.48% |
| 1997 | $1.14 B | 23.06% |
| 1996 | $0.93 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Boston Scientific BSX | $17.55 B | 483.13% | 🇺🇸 USA |
 Merit Medical MMSI | $1.38 B | -53.88% | 🇺🇸 USA |
 AngioDynamics ANGO | $0.28 B | -90.59% | 🇺🇸 USA |
 Abiomed ABMD | $1.07 B | -64.32% | 🇺🇸 USA |
 Becton Dickinson BDX | $20.86 B | 593.22% | 🇺🇸 USA |
 General Electric GE | $39.68 B | 1,218.21% | 🇺🇸 USA |
 Johnson & Johnson JNJ | $89.33 B | 2,867.67% | 🇺🇸 USA |
 Integra LifeSciences IART | $1.62 B | -46.04% | 🇺🇸 USA |
 Cooper Companies COO | $3.98 B | 32.49% | 🇺🇸 USA |